Human Gene MIR136 (ENST00000385207.2) from GENCODE V44
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
Comparative Toxicogenomics Database (CTD)
|
|
The following chemicals interact with this gene
| |
|
|
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
LF205127 - JP 2014500723-A/12630: Polycomb-Associated Non-Coding RNAs. MA440704 - JP 2018138019-A/12630: Polycomb-Associated Non-Coding RNAs. LF209650 - JP 2014500723-A/17153: Polycomb-Associated Non-Coding RNAs. MA445227 - JP 2018138019-A/17153: Polycomb-Associated Non-Coding RNAs. CS266409 - Sequence 101 from Patent WO2005118806. DL076571 - METHODS AND COMPOSITIONS INVOLVING MicroRNA. DM004221 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. FU261185 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763687 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FV525907 - Nucleic acid controling mast cell degranulation. FW421563 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HV304586 - JP 2009531018-A/153: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305084 - JP 2009531019-A/153: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HV491966 - WO 2011087154-A/139: Method For Screening Induced Pluripotent Stem Cells. HW119293 - JP 2013046612-A/153: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW262170 - JP 2013516982-A/139: Method For Screening Induced Pluripotent Stem Cells. HW367434 - JP 2012228254-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW411827 - JP 2014000079-A/101: METHODS AND COMPOSITIONS INVOLVING MicroRNA. HW589622 - JP 2013121348-A/153: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HW674173 - JP 2014217381-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ067115 - JP 2014012020-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ408280 - JP 2015528002-A/877: CHIRAL CONTROL. HZ413426 - JP 2014060993-A/153: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ427539 - JP 2014217384-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ428342 - JP 2014217385-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429145 - JP 2014217386-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429948 - JP 2014217387-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ501637 - JP 2016025853-A/153: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ769205 - JP 2014223080-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. JA058599 - Sequence 101 from Patent EP2298893. JA059402 - Sequence 101 from Patent EP2298894. JA073725 - Sequence 101 from Patent EP2281887. JA104862 - Sequence 101 from Patent EP2302051. JA106202 - Sequence 101 from Patent EP2302052. JA107005 - Sequence 101 from Patent EP2302053. JA107808 - Sequence 101 from Patent EP2302054. JA108611 - Sequence 101 from Patent EP2302055. JA109414 - Sequence 101 from Patent EP2302056. JA191930 - Sequence 101 from Patent EP2290066. JA192829 - Sequence 101 from Patent EP2290067. JA193728 - Sequence 101 from Patent EP2290068. JA194627 - Sequence 101 from Patent EP2290069. JA195526 - Sequence 101 from Patent EP2290070. JA196425 - Sequence 101 from Patent EP2290071. JA197324 - Sequence 101 from Patent EP2290072. JA198223 - Sequence 101 from Patent EP2290073. JA199122 - Sequence 101 from Patent EP2290074. JA200021 - Sequence 101 from Patent EP2290075. JA200920 - Sequence 101 from Patent EP2290076. JA218042 - Sequence 101 from Patent EP2281888. JA226193 - Sequence 101 from Patent EP2292755. JA229048 - Sequence 101 from Patent EP2292756. JA257319 - Sequence 101 from Patent EP2284265. JA278599 - Sequence 101 from Patent EP2281886. JA284485 - Sequence 101 from Patent EP2281889. JA292538 - Sequence 101 from Patent EP2287303. JA317724 - Sequence 101 from Patent EP2314688. JA374783 - Sequence 101 from Patent EP2322616. JA526003 - Sequence 153 from Patent EP2369011. JA526510 - Sequence 153 from Patent EP2369012. JA527017 - Sequence 153 from Patent EP2369013. JA535946 - Sequence 153 from Patent EP2371971. JA787951 - Sequence 153 from Patent EP2479285. JA788449 - Sequence 153 from Patent EP2479286. JA810783 - Sequence 153 from Patent EP2468890. JA811281 - Sequence 153 from Patent EP2468891. JA811779 - Sequence 153 from Patent EP2468893. JA812277 - Sequence 153 from Patent EP2468894. JA812775 - Sequence 153 from Patent EP2468895. JA813273 - Sequence 153 from Patent EP2468896. JA813771 - Sequence 153 from Patent EP2468897. JA814269 - Sequence 153 from Patent EP2468898. JA814767 - Sequence 153 from Patent EP2468899. JA817010 - Sequence 153 from Patent EP2468892. JA825822 - Sequence 153 from Patent EP2471956. JA826320 - Sequence 153 from Patent EP2471958. JB024607 - Sequence 153 from Patent EP2505668. JB025105 - Sequence 153 from Patent EP2505669. JB079492 - Sequence 153 from Patent EP2487252. JB079990 - Sequence 153 from Patent EP2487253. JB080488 - Sequence 153 from Patent EP2487254. JB080986 - Sequence 153 from Patent EP2487255. JB081484 - Sequence 153 from Patent EP2487256. JB081982 - Sequence 153 from Patent EP2487257. JB082480 - Sequence 153 from Patent EP2487258. JB082978 - Sequence 153 from Patent EP2487259. JB083476 - Sequence 153 from Patent EP2487260. JB083974 - Sequence 153 from Patent EP2487261. JB084472 - Sequence 153 from Patent EP2487262. JB084970 - Sequence 153 from Patent EP2487263. JB087648 - Sequence 153 from Patent EP2502630. JB147852 - Sequence 153 from Patent EP2484782. JB148350 - Sequence 153 from Patent EP2484783. JB153075 - Sequence 153 from Patent EP2514433. JB153573 - Sequence 153 from Patent EP2514434. JB622162 - Sequence 153 from Patent EP2586454. JB622660 - Sequence 153 from Patent EP2586455. JC001723 - Sequence 153 from Patent EP2591794. JC208077 - Sequence 139 from Patent EP2524033. JC221626 - Sequence 101 from Patent EP2471923. JC268192 - Sequence 101 from Patent EP2471924. JC340500 - Sequence 101 from Patent EP2471922. JC469746 - Sequence 101 from Patent EP2471921. JC990535 - Sequence 101 from Patent EP2808390. LF714638 - JP 2016165292-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. LF856572 - JP 2015142597-A/101: METHODS AND COMPOSITIONS INVOLVING MicroRNA. LG051614 - KR 1020150036642-A/880: CHIRAL CONTROL. LZ215732 - JP 2017518753-A/83: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS. MP065920 - Sequence 34 from Patent WO2018228875. CS266599 - Sequence 291 from Patent WO2005118806. DL076761 - METHODS AND COMPOSITIONS INVOLVING MicroRNA. DM004411 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. FU261186 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763688 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FW421753 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HV304587 - JP 2009531018-A/154: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305085 - JP 2009531019-A/154: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW119294 - JP 2013046612-A/154: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW367624 - JP 2012228254-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW412017 - JP 2014000079-A/291: METHODS AND COMPOSITIONS INVOLVING MicroRNA. HW589623 - JP 2013121348-A/154: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HW674363 - JP 2014217381-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ067305 - JP 2014012020-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ413427 - JP 2014060993-A/154: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ427729 - JP 2014217384-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ428532 - JP 2014217385-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429335 - JP 2014217386-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ430138 - JP 2014217387-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ501638 - JP 2016025853-A/154: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ769395 - JP 2014223080-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. JA058789 - Sequence 291 from Patent EP2298893. JA059592 - Sequence 291 from Patent EP2298894. JA073915 - Sequence 291 from Patent EP2281887. JA105052 - Sequence 291 from Patent EP2302051. JA106392 - Sequence 291 from Patent EP2302052. JA107195 - Sequence 291 from Patent EP2302053. JA107998 - Sequence 291 from Patent EP2302054. JA108801 - Sequence 291 from Patent EP2302055. JA109604 - Sequence 291 from Patent EP2302056. JA192120 - Sequence 291 from Patent EP2290066. JA193019 - Sequence 291 from Patent EP2290067. JA193918 - Sequence 291 from Patent EP2290068. JA194817 - Sequence 291 from Patent EP2290069. JA195716 - Sequence 291 from Patent EP2290070. JA196615 - Sequence 291 from Patent EP2290071. JA197514 - Sequence 291 from Patent EP2290072. JA198413 - Sequence 291 from Patent EP2290073. JA199312 - Sequence 291 from Patent EP2290074. JA200211 - Sequence 291 from Patent EP2290075. JA201110 - Sequence 291 from Patent EP2290076. JA218232 - Sequence 291 from Patent EP2281888. JA226383 - Sequence 291 from Patent EP2292755. JA229238 - Sequence 291 from Patent EP2292756. JA257509 - Sequence 291 from Patent EP2284265. JA278789 - Sequence 291 from Patent EP2281886. JA284675 - Sequence 291 from Patent EP2281889. JA292728 - Sequence 291 from Patent EP2287303. JA317914 - Sequence 291 from Patent EP2314688. JA374973 - Sequence 291 from Patent EP2322616. JA526004 - Sequence 154 from Patent EP2369011. JA526511 - Sequence 154 from Patent EP2369012. JA527018 - Sequence 154 from Patent EP2369013. JA535947 - Sequence 154 from Patent EP2371971. JA787952 - Sequence 154 from Patent EP2479285. JA788450 - Sequence 154 from Patent EP2479286. JA810784 - Sequence 154 from Patent EP2468890. JA811282 - Sequence 154 from Patent EP2468891. JA811780 - Sequence 154 from Patent EP2468893. JA812278 - Sequence 154 from Patent EP2468894. JA812776 - Sequence 154 from Patent EP2468895. JA813274 - Sequence 154 from Patent EP2468896. JA813772 - Sequence 154 from Patent EP2468897. JA814270 - Sequence 154 from Patent EP2468898. JA814768 - Sequence 154 from Patent EP2468899. JA817011 - Sequence 154 from Patent EP2468892. JA825823 - Sequence 154 from Patent EP2471956. JA826321 - Sequence 154 from Patent EP2471958. JB024608 - Sequence 154 from Patent EP2505668. JB025106 - Sequence 154 from Patent EP2505669. JB079493 - Sequence 154 from Patent EP2487252. JB079991 - Sequence 154 from Patent EP2487253. JB080489 - Sequence 154 from Patent EP2487254. JB080987 - Sequence 154 from Patent EP2487255. JB081485 - Sequence 154 from Patent EP2487256. JB081983 - Sequence 154 from Patent EP2487257. JB082481 - Sequence 154 from Patent EP2487258. JB082979 - Sequence 154 from Patent EP2487259. JB083477 - Sequence 154 from Patent EP2487260. JB083975 - Sequence 154 from Patent EP2487261. JB084473 - Sequence 154 from Patent EP2487262. JB084971 - Sequence 154 from Patent EP2487263. JB087649 - Sequence 154 from Patent EP2502630. JB147853 - Sequence 154 from Patent EP2484782. JB148351 - Sequence 154 from Patent EP2484783. JB153076 - Sequence 154 from Patent EP2514433. JB153574 - Sequence 154 from Patent EP2514434. JB622163 - Sequence 154 from Patent EP2586454. JB622661 - Sequence 154 from Patent EP2586455. JC001724 - Sequence 154 from Patent EP2591794. JC221816 - Sequence 291 from Patent EP2471923. JC268382 - Sequence 291 from Patent EP2471924. JC340690 - Sequence 291 from Patent EP2471922. JC469936 - Sequence 291 from Patent EP2471921. JC990725 - Sequence 291 from Patent EP2808390. LF714828 - JP 2016165292-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. LF856762 - JP 2015142597-A/291: METHODS AND COMPOSITIONS INVOLVING MicroRNA. CQ873655 - Sequence 74 from Patent WO2004076622. CS548275 - Sequence 1305 from Patent EP1777301. DD413492 - Regulation of Mammalian Cells. DJ003759 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof. DJ027038 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof. DJ087829 - Novel miRNA molecules isolated from human embryonic stem cell. FU261423 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763925 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FV524351 - Nucleic acid controling mast cell degranulation. FW312015 - DETECTING NUCLEIC ACIDS. FW364004 - Oligonucleotides for modulating target RNA activity. HI416812 - Sequence 24 from Patent EP2136846. HI965446 - Sequence 731 from Patent WO2010139812. HI965773 - Sequence 93 from Patent WO2010139811. HI966639 - Sequence 93 from Patent WO2010139810. HV304824 - JP 2009531018-A/391: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305322 - JP 2009531019-A/391: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HV492022 - WO 2011087154-A/195: Method For Screening Induced Pluripotent Stem Cells. HV594887 - JP 2010539959-A/268: Micromirs. HV938814 - JP 2011519579-A/1642: Oligonucleotides Containing Arabinose Modified Nucleotides For Treating Inflammation and Neoplastic Cell Proliferation. HV954046 - JP 2012518421-A/958: METHODS OF DETECTING LUNG CANCER. HW119531 - JP 2013046612-A/391: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW262226 - JP 2013516982-A/195: Method For Screening Induced Pluripotent Stem Cells. HW289792 - JP 2013520158-A/35: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION. HW589860 - JP 2013121348-A/391: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HW608531 - JP 2014515024-A/20: Micro-RNA Inhibitors and Their Uses in Disease. HW669299 - JP 2013537538-A/30: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. HZ074121 - JP 2013535982-A/212: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ082915 - JP 2015513906-A/272: Stem Cell Microparticles. HZ157444 - JP 2015130862-A/268: Micromirs. HZ186317 - JP 2015146814-A/66: Oligonucleotides for modulating target RNA activity. HZ392529 - JP 2015180203-A/35: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION. HZ413664 - JP 2014060993-A/391: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ436696 - JP 2015529450-A/272: Stem Cell Microparticles. HZ479793 - JP 2015535430-A/299: TERMINALLY MODIFIED RNA. HZ501875 - JP 2016025853-A/391: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ789724 - JP 2016504050-A/1469: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA401484 - Sequence 731 from Patent WO2011080318. JA402462 - Sequence 731 from Patent WO2011080315. JA403469 - Sequence 731 from Patent WO2011080316. JA406100 - Sequence 731 from Patent EP2336353. JA429626 - Sequence 731 from Patent WO2011095623. JA526241 - Sequence 391 from Patent EP2369011. JA526748 - Sequence 391 from Patent EP2369012. JA527255 - Sequence 391 from Patent EP2369013. JA536184 - Sequence 391 from Patent EP2371971. JA715176 - Sequence 958 from Patent EP2401406. JA788189 - Sequence 391 from Patent EP2479285. JA788687 - Sequence 391 from Patent EP2479286. JA811021 - Sequence 391 from Patent EP2468890. JA811519 - Sequence 391 from Patent EP2468891. JA812017 - Sequence 391 from Patent EP2468893. JA812515 - Sequence 391 from Patent EP2468894. JA813013 - Sequence 391 from Patent EP2468895. JA813511 - Sequence 391 from Patent EP2468896. JA814009 - Sequence 391 from Patent EP2468897. JA814507 - Sequence 391 from Patent EP2468898. JA815005 - Sequence 391 from Patent EP2468899. JA817248 - Sequence 391 from Patent EP2468892. JA821121 - Sequence 1642 from Patent EP2285961. JA826060 - Sequence 391 from Patent EP2471956. JA826558 - Sequence 391 from Patent EP2471958. JB024845 - Sequence 391 from Patent EP2505668. JB025343 - Sequence 391 from Patent EP2505669. JB050174 - Sequence 261 from Patent WO2013020926. JB079730 - Sequence 391 from Patent EP2487252. JB080228 - Sequence 391 from Patent EP2487253. JB080726 - Sequence 391 from Patent EP2487254. JB081224 - Sequence 391 from Patent EP2487255. JB081722 - Sequence 391 from Patent EP2487256. JB082220 - Sequence 391 from Patent EP2487257. JB082718 - Sequence 391 from Patent EP2487258. JB083216 - Sequence 391 from Patent EP2487259. JB083714 - Sequence 391 from Patent EP2487260. JB084212 - Sequence 391 from Patent EP2487261. JB084710 - Sequence 391 from Patent EP2487262. JB085208 - Sequence 391 from Patent EP2487263. JB087886 - Sequence 391 from Patent EP2502630. JB148090 - Sequence 391 from Patent EP2484782. JB148588 - Sequence 391 from Patent EP2484783. JB153313 - Sequence 391 from Patent EP2514433. JB153811 - Sequence 391 from Patent EP2514434. JB158032 - Sequence 20 from Patent WO2012142313. JB175225 - Sequence 257 from Patent WO2012101219. JB620297 - Sequence 277 from Patent WO2013063544. JB622400 - Sequence 391 from Patent EP2586454. JB622898 - Sequence 391 from Patent EP2586455. JB835765 - Sequence 55 from Patent WO2013057567. JC001961 - Sequence 391 from Patent EP2591794. JC171900 - Sequence 272 from Patent WO2013150303. JC208133 - Sequence 195 from Patent EP2524033. JC269639 - Sequence 30 from Patent WO2012020307. JC334117 - Sequence 35 from Patent EP2487240. JC512456 - Sequence 2709 from Patent WO2014113089. JC572711 - Sequence 272 from Patent WO2014125276. JC582399 - Sequence 272 from Patent WO2014125277. JE954095 - Sequence 272 from Patent WO2015052526. JE955848 - Sequence 272 from Patent WO2015052527. LF137600 - JP 2016507550-A/272: Method of Producing Microparticles. LF160853 - JP 2016513950-A/919: Oligomers with improved off-target profile. LF162565 - JP 2016513095-A/272: Stem Cell Microparticles and miRNA. LF953317 - JP 2016534103-A/272: Stem Cell Microparticles and miRNA. LG005662 - KR 1020150004822-A/272: STEM CELL MICROPARTICLES. LG053358 - KR 1020150059168-A/272: STEM CELL MICROPARTICLES. LG240597 - KR 1020160035087-A/272: STEM CELL MICROPARTICLES AND MIRNA. LP726399 - Sequence 93 from Patent EP2883966. LP769610 - Sequence 137 from Patent EP3294910. LP818669 - Sequence 93 from Patent EP3296406. LP938611 - Sequence 93 from Patent EP3184651. LP951827 - Sequence 333 from Patent WO2017157650. LQ070044 - Sequence 368 from Patent EP2964234. LQ278468 - Sequence 7 from Patent WO2016066288. LQ420444 - Sequence 20 from Patent WO2016127998. LV470682 - JP 2016534036-A/272: Stem Cell Microparticles and miRNA. LX270096 - JP 2016056210-A/30: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. LY404952 - KR 1020160117535-A/257: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LY504775 - KR 1020170035932-A/164: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER. LZ233674 - JP 2017184756-A/66: Oligonucleotides for modulating target RNA activity. LZ243056 - JP 2017525350-A/164: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER. MA260191 - JP 2017505623-A/257: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA400950 - JP 2018515097-A/137: Method for Diagnosis and Prognosis of Chronic Heart Failure. MA643545 - JP 2017113010-A/1469: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA730243 - JP 2017125065-A/30: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. MA731429 - JP 2017140048-A/299: TERMINALLY MODIFIED RNA. MA783860 - WO 2018181877-A/1: Anti-cancer agent using miRNA. MP065921 - Sequence 35 from Patent WO2018228875. MP070538 - Sequence 135 from Patent WO2018231851. MS834585 - Sequence 731 from Patent EP3112479. MS944908 - Sequence 164 from Patent EP3177739. MA403155 - JP 2018131391-A/2: MicroRNA formation inhibitor and method for producing the same. AY882312 - Homo sapiens microRNA HSA-MIR-RG-81, complete sequence. FW364005 - Oligonucleotides for modulating target RNA activity. HI965445 - Sequence 730 from Patent WO2010139812. HI966178 - Sequence 498 from Patent WO2010139811. HI967044 - Sequence 498 from Patent WO2010139810. HV492023 - WO 2011087154-A/196: Method For Screening Induced Pluripotent Stem Cells. HV594888 - JP 2010539959-A/269: Micromirs. HV938815 - JP 2011519579-A/1643: Oligonucleotides Containing Arabinose Modified Nucleotides For Treating Inflammation and Neoplastic Cell Proliferation. HW262227 - JP 2013516982-A/196: Method For Screening Induced Pluripotent Stem Cells. HW669300 - JP 2013537538-A/31: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. HW913354 - JP 2015504307-A/114: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS. HZ074122 - JP 2013535982-A/213: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ082725 - JP 2015513906-A/82: Stem Cell Microparticles. HZ157445 - JP 2015130862-A/269: Micromirs. HZ186318 - JP 2015146814-A/67: Oligonucleotides for modulating target RNA activity. HZ436506 - JP 2015529450-A/82: Stem Cell Microparticles. HZ479792 - JP 2015535430-A/298: TERMINALLY MODIFIED RNA. HZ789723 - JP 2016504050-A/1468: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA401483 - Sequence 730 from Patent WO2011080318. JA402461 - Sequence 730 from Patent WO2011080315. JA403468 - Sequence 730 from Patent WO2011080316. JA406099 - Sequence 730 from Patent EP2336353. JA429625 - Sequence 730 from Patent WO2011095623. JA660584 - Sequence 38 from Patent WO2011131354. JA757959 - Sequence 92 from Patent WO2012010584. JA808552 - Sequence 24 from Patent WO2012083969. JA821122 - Sequence 1643 from Patent EP2285961. JB022640 - Sequence 482 from Patent WO2013026685. JB620298 - Sequence 278 from Patent WO2013063544. JB778735 - Sequence 114 from Patent WO2013078283. JC171710 - Sequence 82 from Patent WO2013150303. JC208134 - Sequence 196 from Patent EP2524033. JC269640 - Sequence 31 from Patent WO2012020307. JC512455 - Sequence 2708 from Patent WO2014113089. JC572521 - Sequence 82 from Patent WO2014125276. JC582209 - Sequence 82 from Patent WO2014125277. JE953905 - Sequence 82 from Patent WO2015052526. JE955658 - Sequence 82 from Patent WO2015052527. JE978593 - Sequence 38 from Patent EP2865765. LF137410 - JP 2016507550-A/82: Method of Producing Microparticles. LF160226 - JP 2016513950-A/292: Oligomers with improved off-target profile. LF162375 - JP 2016513095-A/82: Stem Cell Microparticles and miRNA. LF953127 - JP 2016534103-A/82: Stem Cell Microparticles and miRNA. LG005472 - KR 1020150004822-A/82: STEM CELL MICROPARTICLES. LG053168 - KR 1020150059168-A/82: STEM CELL MICROPARTICLES. LG240407 - KR 1020160035087-A/82: STEM CELL MICROPARTICLES AND MIRNA. LP726804 - Sequence 498 from Patent EP2883966. LP819074 - Sequence 498 from Patent EP3296406. LP939016 - Sequence 498 from Patent EP3184651. LQ070043 - Sequence 367 from Patent EP2964234. LQ724524 - Sequence 157 from Patent WO2018096084. LV470492 - JP 2016534036-A/82: Stem Cell Microparticles and miRNA. LX270097 - JP 2016056210-A/31: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. LY404953 - KR 1020160117535-A/258: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LY504658 - KR 1020170035932-A/47: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER. LZ215685 - JP 2017518753-A/36: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS. LZ233675 - JP 2017184756-A/67: Oligonucleotides for modulating target RNA activity. LZ242939 - JP 2017525350-A/47: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER. MA260192 - JP 2017505623-A/258: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA643544 - JP 2017113010-A/1468: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA730244 - JP 2017125065-A/31: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. MA731428 - JP 2017140048-A/298: TERMINALLY MODIFIED RNA. MP065889 - Sequence 3 from Patent WO2018228875. MS637915 - Sequence 32 from Patent WO2017037190. MS834584 - Sequence 730 from Patent EP3112479. MS902009 - Sequence 482 from Patent EP3156505. MS944791 - Sequence 47 from Patent EP3177739. MA800598 - JP 2018183181-A/1469: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA800597 - JP 2018183181-A/1468: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MP129372 - Sequence 272 from Patent EP3470073. MP162295 - Sequence 272 from Patent WO2019069093. MP129182 - Sequence 82 from Patent EP3470073. MP162105 - Sequence 82 from Patent WO2019069093. MB018391 - JP 2018504915-A/20: A microRNA-based method for early detection of prostate cancer in urine samples. MP280686 - Sequence 106 from Patent WO2019111197. MP272086 - Sequence 34 from Patent WO2019157381. MP283599 - Sequence 106 from Patent WO2019111198. MB453613 - JP 2018509178-A/179: Methods for Highly Parallel and Accurate Measurement of Nucleic Acids.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: ENST00000385207.1, NR_029699, uc010txk.1, uc010txk.2, uc010txk.3 UCSC ID: ENST00000385207.2 RefSeq Accession: NR_029699
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|